GC Medical Science Corporation (KOSDAQ:142280)
South Korea · Delayed Price · Currency is KRW 2,885.00
-10.00 (-0.35%)
At close: Nov 13, 2026
GC Medical Science Market Cap
GC Medical Science has a market cap or net worth of 69.13 billion as of November 13, 2026. It is the 29,603rd most valuable company in the world and the 1,493rd biggest in South Korea. Its market cap has decreased by 26.05% in one year.
Market Cap
69.13B
Enterprise Value
86.19B
Revenue
102.16B
Global Rank
Country Rank
#1,493 South Korea
PE Ratio
n/a
ChartMarket Cap Chart
Since December 17, 2014, GC Medical Science's market cap has decreased from 98.95B to 69.13B, a decrease of -30.13%. That is a compound annual growth rate of -2.96%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 13, 2026 | 69.13B | -20.61% |
| Dec 30, 2025 | 87.08B | 12.05% |
| Dec 30, 2024 | 77.71B | -22.72% |
| Dec 28, 2023 | 100.56B | -17.47% |
| Dec 29, 2022 | 121.86B | -20.00% |
| Dec 30, 2021 | 152.32B | -53.95% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| 3billion | 204.94B |
| Dx & Vx | 194.89B |
| Protia | 62.60B |
| Inventera | 58.28B |
| GENINUS | 52.39B |
| Cytogen | 51.57B |
| HLB Panagene | 48.08B |
| Seoulin Bioscience | 29.23B |